Tin tức & Cập nhật
Xem bài viết Ung thư
Xem
Chỉ hiển thị Multimedia

Dalpiciclib-pyrotinib-endocrine therapy passes trial for breast cancer
25 Aug 2025
bởiStephen Padilla
Treatment with dalpiciclib combined with pyrotinib and endocrine therapy exhibits antitumour activity with no new safety signals in estrogen receptor (ER)-positive HER2-positive advanced breast cancer, as shown by the results of a phase II trial.
25 Aug 2025

Lung nodule surveillance programme helps detect early-stage lung cancer
22 Aug 2025
bởiChristina Lau
A lung nodule surveillance programme at Queen Mary Hospital (QMH) facilitates diagnosis of early-stage lung cancer. Data from the programme’s first year of implementation showed a higher proportion of early-stage lung cancer diagnoses compared with the Hong Kong Cancer Registry’s (HKCR) annual report.
22 Aug 2025






